Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam Adjunctive Therapy for PGTC Seizures
NCT00160550Phase 3Completed
- Sponsor
- UCB
- Start
- Sep 2001
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in idiopathic generalized epilepsy (IGE) comparing Levetiracetam with Placebo (2 arms). Primary endpoint: Percentage reduction in PGTC seizure frequency per week. Started Sep 2001; status: completed.
02
Drugs
levetiracetam
03
Conditions
idiopathic generalized epilepsy (IGE)
Beyond the preview
Go deeper on NCT00160550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160550.